• 8059 Citations
  • 48 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

바이러스성 간염(분자생물학, 신약개발, 약제내성치료)
간경변증, 간암(병태생리, 신치료)

Professional Information

세브란스병원 전공의, 강사, 조교수 역임, 현) 연세의대 내과학 교실 교수
현) 세브란스 병원 진료협력 센터 소장
현) 간경변임상연구소 총무간사
다국적 제약회사들의 신약개발 국제자문위원(Gilead, BMS, Norvatis, Roche, MSD, Behringer Ingelheim, etc)

Personal profile

1995. 연세대학교 의학과 학사 
1998. 연세대학교 의학과 석사 
2003. 연세대학교 의과학과 박사

Fingerprint Dive into the research topics where SangHoon Ahn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Chronic Hepatitis B Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Liver Medicine & Life Sciences
Liver Cirrhosis Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Elasticity Imaging Techniques Medicine & Life Sciences
Lamivudine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

1 Citation (Scopus)

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea

Kim, S., Seo, Y. S., Lee, H. A., Kim, M. N., Lee, Y. R., Lee, H. W., Park, J., kim, D., Ahn, S., Han, K., Hwang, S. G., Rim, K. S., Um, S. H., Tak, W. Y., Kweon, Y. O., Kim, B. K. & Park, S. Y., 2019 Sep 1, In : Journal of Hepatology. 71, 3, p. 456-464 9 p.

Research output: Contribution to journalArticle

Tenofovir
Republic of Korea
Chronic Hepatitis B
Multicenter Studies
Antiviral Agents

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals

Lee, H. W., Kim, S., Oidov, B., Park, J., kim, D., Ahn, S., Han, K. & Kim, B. K., 2019 Dec 1, In : Scientific reports. 9, 1, 2508.

Research output: Contribution to journalArticle

Open Access
Chronic Hepatitis B
Antiviral Agents
Propensity Score
Liver
Virus Diseases

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis (Digestive Diseases and Sciences, (2018), 63, 12, (3487-3497), 10.1007/s10620-018-5251-9)

Ahn, S., Marcellin, P., Ma, X., Caruntu, F. A., Tak, W. Y., Elkhashab, M., Chuang, W. L., Tabak, F., Mehta, R., Petersen, J., Guyer, W., Jump, B., Chan, A., Subramanian, M., Crans, G., Fung, S., Buti, M., Gaeta, G. B., Hui, A. J., Papatheodoridis, G. & 2 others, Flisiak, R. & Chan, H. L. Y., 2019 Jan 1, In : Digestive diseases and sciences. 64, 1, p. 285-286 2 p.

Research output: Contribution to journalComment/debate

Tenofovir
Hepatitis B Surface Antigens
Genotype
Safety
DNA

Development of a new nomogram including neutrophil-to-lymphocyte ratio to predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

Chon, Y. E., Park, H., Hyun, H. K., Ha, Y., Kim, M. N., Kim, B. K., Lee, J. H., Kim, S., kim, D., Ahn, S., Hwang, S. G., Han, K., Rim, K. S. & Park, J., 2019 Apr 1, In : Cancers. 11, 4, 509.

Research output: Contribution to journalArticle

Open Access
Nomograms
Hepatocellular Carcinoma
Neutrophils
Lymphocytes
Survival
Chronic Hepatitis B
Antiviral Agents
Hepatocellular Carcinoma
Tenofovir
Lamivudine